Clinical Trial Update: Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether OM-89 reduces antibiotic use for urinary tract infections in patients with neurogenic bladder compared with place…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Urinary Tract Infection

Drugs mentioned

• OM-89 (Escherichia coli lysate OM-89)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Neurogenic Bladder | Phase 3 | Status: RECRUITING